iShares Nasdaq US Biotechnology UCITS ETF USD (Acc)
2B70ETF€9.16+0.87%Today
24h Range
€8.97€9.18
Market Overview
Total Assets€522.30M
Expense Ratio0.35%
52W High€9.18
52W Low€5.80
Technicals
50-Day MA€8.36
200-Day MA€7.55
Risk Metrics
1Y Volatility15.50%
3Y Volatility16.92%
Sharpe Ratio (3Y)0.71
Portfolio Allocation
US Stock94.7%
Non-US Stock5.2%
Cash0.2%
Recently Happened
Loading...
iShares Nasdaq US Biotechnology UCITS ETF USD (Acc)
2B70ETF€9.16+0.87%Today
24h Range
€8.97€9.18
Market Overview
Total Assets€522.30M
Expense Ratio0.35%
52W High€9.18
52W Low€5.80
Technicals
50-Day MA€8.36
200-Day MA€7.55
Risk Metrics
1Y Volatility15.50%
3Y Volatility16.92%
Sharpe Ratio (3Y)0.71
Portfolio Allocation
US Stock94.7%
Non-US Stock5.2%
Cash0.2%
Recently Happened
Loading...
Performance
YTD
+27.60%
1Y
+55.77%
3Y
+22.15%
5Y
+7.38%
Portfolio Allocation
US Stock94.7%
Non-US Stock5.2%
Cash0.2%
Top 10 Holdings
10 holdings total1Amgen Inc
8.57%AMGN
2Vertex Pharmaceuticals Inc
7.99%VRTX
3Gilead Sciences Inc
7.26%GILD
4Regeneron Pharmaceuticals Inc
5.62%REGN
5Revolution Medicines Inc
2.85%RVMD
6Illumina Inc
2.22%ILMN
7Biogen Inc
2.14%BIIB
8Alnylam Pharmaceuticals Inc
1.96%ALNY
9Royalty Pharma Plc
1.85%RPRX
10Roivant Sciences Ltd
1.74%ROIV
Top 10 Total42.21%
| # | Name | Ticker | Weight |
|---|---|---|---|
| 1 | Amgen Inc | AMGN | 8.57% |
| 2 | Vertex Pharmaceuticals Inc | VRTX | 7.99% |
| 3 | Gilead Sciences Inc | GILD | 7.26% |
| 4 | Regeneron Pharmaceuticals Inc | REGN | 5.62% |
| 5 | Revolution Medicines Inc | RVMD | 2.85% |
| 6 | Illumina Inc | ILMN | 2.22% |
| 7 | Biogen Inc | BIIB | 2.14% |
| 8 | Alnylam Pharmaceuticals Inc | ALNY | 1.96% |
| 9 | Royalty Pharma Plc | RPRX | 1.85% |
| 10 | Roivant Sciences Ltd | ROIV | 1.74% |
| Top 10 Total | 42.21% | ||
Performance
YTD
+27.60%
1Y
+55.77%
3Y
+22.15%
5Y
+7.38%
Portfolio Allocation
US Stock94.7%
Non-US Stock5.2%
Cash0.2%
Top 10 Holdings
10 holdings total1Amgen Inc
8.57%AMGN
2Vertex Pharmaceuticals Inc
7.99%VRTX
3Gilead Sciences Inc
7.26%GILD
4Regeneron Pharmaceuticals Inc
5.62%REGN
5Revolution Medicines Inc
2.85%RVMD
6Illumina Inc
2.22%ILMN
7Biogen Inc
2.14%BIIB
8Alnylam Pharmaceuticals Inc
1.96%ALNY
9Royalty Pharma Plc
1.85%RPRX
10Roivant Sciences Ltd
1.74%ROIV
Top 10 Total42.21%
| # | Name | Ticker | Weight |
|---|---|---|---|
| 1 | Amgen Inc | AMGN | 8.57% |
| 2 | Vertex Pharmaceuticals Inc | VRTX | 7.99% |
| 3 | Gilead Sciences Inc | GILD | 7.26% |
| 4 | Regeneron Pharmaceuticals Inc | REGN | 5.62% |
| 5 | Revolution Medicines Inc | RVMD | 2.85% |
| 6 | Illumina Inc | ILMN | 2.22% |
| 7 | Biogen Inc | BIIB | 2.14% |
| 8 | Alnylam Pharmaceuticals Inc | ALNY | 1.96% |
| 9 | Royalty Pharma Plc | RPRX | 1.85% |
| 10 | Roivant Sciences Ltd | ROIV | 1.74% |
| Top 10 Total | 42.21% | ||
Technical Analysis
This info isn't a recommendation for what you should personally do, so please don't take the data as investment advice. As with any trade, always look first, then leap.
Trade iShares Nasdaq US Biotechnology UCITS ETF USD (Acc)